Yu Hong Geng
Nessuna posizione attualmente
Storia della carriera di Yu Hong Geng
Precedenti posizioni note di Yu Hong Geng
Società | Posizione | Inizio | Fine |
---|---|---|---|
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of United Laboratories, Inc., Shanghai United Cell Biotechnology Co. Ltd. is an industrialized base that integrates the research and development, manufacturing, and sales of genetic reorganization biological products and vaccines. The company is based in Shanghai, China. The Chinese company has always adhered to the principle of developing high-quality drugs and vaccine products through innovation to better serve society and benefit humanity. The company's products include injection reorganization typa peptide reorganization B sub-sub-unit/bacterial cholera vaccine, injection of employment growth hormone in employment hormone. | Direttore Tecnico/Scientifico/R&S | 01/03/2004 | 01/07/2014 |
Corporate Officer/Principal | 01/07/2014 | 01/04/2021 | |
BIOTON S.A. | Direttore/Membro del Consiglio | - | - |
Formazione di Yu Hong Geng
University of Hong Kong | Doctorate Degree |
Fudan University | Graduate Degree |
Statistiche
Distribuzione geografica
Cina | 3 |
Polonia | 2 |
Hong Kong | 2 |
Posizioni
Director/Board Member | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIOTON S.A. | Health Technology |
Aziende private | 1 |
---|---|
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of United Laboratories, Inc., Shanghai United Cell Biotechnology Co. Ltd. is an industrialized base that integrates the research and development, manufacturing, and sales of genetic reorganization biological products and vaccines. The company is based in Shanghai, China. The Chinese company has always adhered to the principle of developing high-quality drugs and vaccine products through innovation to better serve society and benefit humanity. The company's products include injection reorganization typa peptide reorganization B sub-sub-unit/bacterial cholera vaccine, injection of employment growth hormone in employment hormone. | Health Technology |
- Borsa valori
- Insiders
- Yu Hong Geng
- Esperienza